当前位置：
X-MOL 学术
›
Int. Arch. Allergy Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
High-Dose Omalizumab versus Ligelizumab for the Treatment of Chronic Spontaneous Urticaria: Do Not We Need a Head-To-Head Comparison?
International Archives of Allergy and Immunology ( IF 2.8 ) Pub Date : 2020-12-15 , DOI: 10.1159/000512373 Murat Türk 1 , İnsu Yılmaz 2
Int Arch Allergy Immunol
中文翻译：
高剂量奥马珠单抗与 Ligelizumab 治疗慢性自发性荨麻疹：我们不需要正面比较吗？
Int Arch 过敏免疫
更新日期：2020-12-15
International Archives of Allergy and Immunology ( IF 2.8 ) Pub Date : 2020-12-15 , DOI: 10.1159/000512373 Murat Türk 1 , İnsu Yılmaz 2
Affiliation
Int Arch Allergy Immunol
中文翻译：
高剂量奥马珠单抗与 Ligelizumab 治疗慢性自发性荨麻疹：我们不需要正面比较吗？
Int Arch 过敏免疫
京公网安备 11010802027423号